Ideas

November 6, 2017

Published by admin_auro at November 6, 2017

Categories

Combinatorial Antiviral Therapy (CAT): A pharmaceutical mixture encompassing Andrographolide and Nordihydroguaiaretic acid (NDGA) inhibits Hepatitis-B/C, Dengue, Zika, Ebola, HIV-1, Mtb, Malaria, CMV, SARS. Influenza H1NI1, respiratory syncytical , Sindbis, and SFV viruses by increasing the Levels of the Antiviral Proteins IFITM3, & Interferon-stimulated gene 15, 7/November/2017, 12.27 am

Introduction: What they say: A study from the Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard Medical School, Charlestown, MA 02129, USA […]

November 6, 2017

Published by admin_auro at November 6, 2017

Categories

Molecular therapy for heart regeneration and repair: A therapeutic mix encompassing Atorvastatin and Amlodipine increases Agrin expression, activates Yap and ERK-mediated signaling, replaces scar tissue with functional cardiomyocytes, and promotes cardiomyocyte regeneration and repair after myocardial infarction, via up regulation of its target gene, 7/November/2017, 12.03 am

Introduction: What they say: A recent study from Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 76100, Israel; Department of Biomedical Engineering, Duke University, […]

November 6, 2017

Published by admin_auro at November 6, 2017

Categories

Ideas
Pain

PD-1 pathway activation for Pain therapy: Lipofen/Fenoglide/Tricor, a lipid-lowreing medication, increases the expression of PD-L1, attenuates acutes and chronic pain, and suppresses mechanical and thermal hypersensitivity and inhibits nociceptive neuron excitability via up-regulation of its target gen, 6/November/2017, 11.39 pm

Introduction:What they say: A recent study from Institute of Neurobiology, Institutes of Brain Science and State Key Laboratory of Medical Neurobiology, Collaborative Innovation Center for Brain […]

November 6, 2017

Published by admin_auro at November 6, 2017

Categories

Antiviral therapy for HIV virus: Nafamostat Mesilate increases Heme oxygenase 2 (HO-2) expression, blocks N-myristoylation of HIV-1 Gag protein, disrupts HIV-1 budding, and restricts HIV-1 production via up regulation of its target gene, 6/November/2017, 11.18 pm

What we say: Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Antiviral therapy for HIV virus: Nafamostat Mesilate increases Heme oxygenase 2 (HO-2) expression, blocks N-myristoylation […]